CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The company says it has confirmed its existing diagnostic tests to detect SARS-CoV-2 are not affected by known mutations and remain accurate and effective in detecting active infections. Roche is conducting assessments on a regular basis and will continue to monitor as new variants arise.
Pages: 1 2